cardiovascular system
| N |
• mice exhibit normal basal left ventricle function, cardiac morphometry, contractile function
|
|
• increased cell death following ischemic/reperfusion injury
|
|
• following ischemic/reperfusion injury, mice exhibit increased infarct size, superoxide levels and cardiomyocyte cell death compared with wild-type mice
|
|
• following ischemic/reperfusion injury
• however, treatment with SB239063 (a selective p38/Mapk14 inhibitor) decreased size
|
cellular
|
• basal and post-ischemic/reperfusion injury superoxide levels are increased compared with wild-type mice
|
homeostasis/metabolism
|
• following ischemic/reperfusion injury, mice exhibit increased infarct size, superoxide levels and cardiomyocyte cell death compared with wild-type mice
|
|
• following ischemic/reperfusion injury
• however, treatment with SB239063 (a selective p38/Mapk14 inhibitor) decreased size
|


Analysis Tools